LivePerson, Inc. (NASDAQ:LPSN – Get Rating) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 5,760,000 shares, a decline of 8.1% from the April 15th total of 6,270,000 shares. Based on an average daily trading volume, of 1,980,000 shares, the days-to-cover ratio is currently 2.9 days.
Insiders Place Their Bets
In other LivePerson news, Director William Wesemann bought 20,000 shares of the company’s stock in a transaction on Thursday, March 23rd. The shares were bought at an average cost of $3.91 per share, with a total value of $78,200.00. Following the completion of the acquisition, the director now owns 214,954 shares of the company’s stock, valued at $840,470.14. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 14,659 shares of company stock worth $66,069 over the last ninety days. 9.00% of the stock is owned by company insiders.
Institutional Trading of LivePerson
A number of institutional investors have recently added to or reduced their stakes in LPSN. Schonfeld Strategic Advisors LLC purchased a new stake in LivePerson in the 1st quarter worth approximately $300,000. Two Sigma Advisers LP lifted its stake in shares of LivePerson by 233.3% in the 1st quarter. Two Sigma Advisers LP now owns 691,000 shares of the technology company’s stock valued at $3,047,000 after purchasing an additional 483,700 shares during the period. Two Sigma Investments LP raised its stake in LivePerson by 1,629.1% during the first quarter. Two Sigma Investments LP now owns 1,082,447 shares of the technology company’s stock valued at $4,774,000 after buying an additional 1,019,847 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in LivePerson by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 47,958 shares of the technology company’s stock valued at $212,000 after buying an additional 3,289 shares during the last quarter. Finally, XTX Topco Ltd bought a new stake in shares of LivePerson in the 1st quarter worth $221,000. Hedge funds and other institutional investors own 86.39% of the company’s stock.
Analysts Set New Price Targets
LivePerson Price Performance
Shares of LPSN opened at $4.37 on Tuesday. LivePerson has a 52-week low of $3.57 and a 52-week high of $18.17. The company has a debt-to-equity ratio of 10.83, a quick ratio of 2.10 and a current ratio of 2.10. The business’s 50 day moving average price is $5.25 and its two-hundred day moving average price is $9.57. The firm has a market cap of $345.08 million, a PE ratio of -1.88 and a beta of 1.52.
LivePerson (NASDAQ:LPSN – Get Rating) last announced its quarterly earnings results on Wednesday, March 15th. The technology company reported ($0.41) earnings per share (EPS) for the quarter. LivePerson had a negative return on equity of 156.62% and a negative net margin of 43.85%. The company had revenue of $122.48 million for the quarter, compared to the consensus estimate of $126.97 million. On average, equities analysts anticipate that LivePerson will post -1 EPS for the current year.
LivePerson, Inc engages in the provision of mobile and online messaging solutions through Conversational Artificial Intelligence. Conversational AI allows humans and machines to interact using natural language, including speech or text. It operates through the Business and Consumer segments. The Business segment enables brands to leverage the intelligence engine of Conversational Cloud, the firm’s enterprise-class cloud-based platform, to connect with consumers through an integrated suite of mobile and online business messaging technologies.
- Get a free copy of the StockNews.com research report on LivePerson (LPSN)
- FREYR Battery Is An Interesting Play On EVs: At Rock Bottom
- Analysts Upgrade GXO Logistics, Its First Quarter Says It All
- The Bottom Is In For AppLovin; Reversal Is Next
- Exact Sciences Serves Investors Exactly What They Wished For
- Shockwave Medical, Fast Grower, In Boston Scientific’s Sights?
Receive News & Ratings for LivePerson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivePerson and related companies with MarketBeat.com's FREE daily email newsletter.